AVDL - Avadel Pharmaceuticals PLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AVDL is currently covered by 7 analysts with an average price target of $15.16. This is a potential upside of $6.39 (72.86%) from yesterday's end of day stock price of $8.77.

Avadel Pharmaceuticals PLC's activity chart (see below) currently has 62 price targets and 94 ratings on display. The stock rating distribution of AVDL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 52.71% with an average time for these price targets to be met of 553.36 days.

Highest price target for AVDL is $30, Lowest price target is $13, average price target is $19.17.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 09-Apr-2025. First documented stock forecast 20-Mar-2015.

Currently out of the existing stock ratings of AVDL, 50 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$19

$10.97 (136.61%)

$19

16 days ago
(09-Apr-2025)

20/34 (58.82%)

$11.74 (161.71%)

319

Buy

$21

$12.97 (161.52%)

$21

1 months 21 days ago
(04-Mar-2025)

4/14 (28.57%)

$13.36 (174.87%)

380

Buy

$14

$5.97 (74.35%)

$22

3 months 12 days ago
(13-Jan-2025)

0/4 (0%)

$6.18 (79.03%)

Buy

$13

$4.97 (61.89%)

$23

3 months 15 days ago
(10-Jan-2025)

4/6 (66.67%)

$5.1 (64.56%)

1060

Buy

$30

$21.97 (273.60%)

$29

5 months 25 days ago
(31-Oct-2024)

5/14 (35.71%)

$14.53 (93.92%)

404

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AVDL (Avadel Pharmaceuticals PLC) average time for price targets to be met?

On average it took 553.36 days on average for the stock forecasts to be realized with a an average price target met ratio 52.71

Which analyst has the current highest performing score on AVDL (Avadel Pharmaceuticals PLC) with a proven track record?

DAVID AMSELLEM

Which analyst has the most public recommendations on AVDL (Avadel Pharmaceuticals PLC)?

David Amsellem works at PIPER SANDLER and has 7 price targets and 4 ratings on AVDL

Which analyst is the currently most bullish on AVDL (Avadel Pharmaceuticals PLC)?

Francois Brisebois with highest potential upside - $21.97

Which analyst is the currently most reserved on AVDL (Avadel Pharmaceuticals PLC)?

Paul Matteis with lowest potential downside - -$1.03

Avadel Pharmaceuticals PLC in the News

Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025

Avadel Pharmaceuticals (AVDL) said Tuesday it expects to generate “sustainable positive cash flow” i PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

DUBLIN, April 08, 2025 (GLOBE NEWSWIRE) —  Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today presented at the 24th Annual Needham Virtual Healthcare Conference. The Company provided an update on patient demand metrics that was in line with guidance from its full-year results announcement on March 3,...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?